106 related articles for article (PubMed ID: 11681417)
1. Effects of overexpression of the SH2-containing inositol phosphatase SHIP on proliferation and apoptosis of erythroid AS-E2 cells.
Boer AK; Drayer AL; Vellenga E
Leukemia; 2001 Nov; 15(11):1750-7. PubMed ID: 11681417
[TBL] [Abstract][Full Text] [Related]
2. Critical role for PI 3-kinase in the control of erythropoietin-induced erythroid progenitor proliferation.
Bouscary D; Pene F; Claessens YE; Muller O; Chrétien S; Fontenay-Roupie M; Gisselbrecht S; Mayeux P; Lacombe C
Blood; 2003 May; 101(9):3436-43. PubMed ID: 12506011
[TBL] [Abstract][Full Text] [Related]
3. PTEN, but not SHIP and SHIP2, suppresses the PI3K/Akt pathway and induces growth inhibition and apoptosis of myeloma cells.
Choi Y; Zhang J; Murga C; Yu H; Koller E; Monia BP; Gutkind JS; Li W
Oncogene; 2002 Aug; 21(34):5289-300. PubMed ID: 12149650
[TBL] [Abstract][Full Text] [Related]
4. Heterologous regulation of chemokine receptor signaling by the lipid phosphatase SHIP in lymphocytes.
Wain CM; Westwick J; Ward SG
Cell Signal; 2005 Oct; 17(10):1194-202. PubMed ID: 16038794
[TBL] [Abstract][Full Text] [Related]
5. Phosphatidylinositol (3,4,5)P3 is essential but not sufficient for protein kinase B (PKB) activation; phosphatidylinositol (3,4)P2 is required for PKB phosphorylation at Ser-473: studies using cells from SH2-containing inositol-5-phosphatase knockout mice.
Scheid MP; Huber M; Damen JE; Hughes M; Kang V; Neilsen P; Prestwich GD; Krystal G; Duronio V
J Biol Chem; 2002 Mar; 277(11):9027-35. PubMed ID: 11781306
[TBL] [Abstract][Full Text] [Related]
6. Evidence that SHIP-1 contributes to phosphatidylinositol 3,4,5-trisphosphate metabolism in T lymphocytes and can regulate novel phosphoinositide 3-kinase effectors.
Freeburn RW; Wright KL; Burgess SJ; Astoul E; Cantrell DA; Ward SG
J Immunol; 2002 Nov; 169(10):5441-50. PubMed ID: 12421919
[TBL] [Abstract][Full Text] [Related]
7. The inositol 5'-phosphatase SHIP-1 and the Src kinase Lyn negatively regulate macrophage colony-stimulating factor-induced Akt activity.
Baran CP; Tridandapani S; Helgason CD; Humphries RK; Krystal G; Marsh CB
J Biol Chem; 2003 Oct; 278(40):38628-36. PubMed ID: 12882960
[TBL] [Abstract][Full Text] [Related]
8. SHIP negatively regulates IgE + antigen-induced IL-6 production in mast cells by inhibiting NF-kappa B activity.
Kalesnikoff J; Baur N; Leitges M; Hughes MR; Damen JE; Huber M; Krystal G
J Immunol; 2002 May; 168(9):4737-46. PubMed ID: 11971024
[TBL] [Abstract][Full Text] [Related]
9. Lipopolysaccharide-induced macrophage inflammatory response is regulated by SHIP.
Fang H; Pengal RA; Cao X; Ganesan LP; Wewers MD; Marsh CB; Tridandapani S
J Immunol; 2004 Jul; 173(1):360-6. PubMed ID: 15210794
[TBL] [Abstract][Full Text] [Related]
10. Activation of the Akt/FKHRL1 pathway mediates the antiapoptotic effects of erythropoietin in primary human erythroid progenitors.
Uddin S; Kottegoda S; Stigger D; Platanias LC; Wickrema A
Biochem Biophys Res Commun; 2000 Aug; 275(1):16-9. PubMed ID: 10944433
[TBL] [Abstract][Full Text] [Related]
11. The inositol phosphatase SHIP-1 is negatively regulated by Fli-1 and its loss accelerates leukemogenesis.
Lakhanpal GK; Vecchiarelli-Federico LM; Li YJ; Cui JW; Bailey ML; Spaner DE; Dumont DJ; Barber DL; Ben-David Y
Blood; 2010 Jul; 116(3):428-36. PubMed ID: 20445019
[TBL] [Abstract][Full Text] [Related]
12. 5' phospholipid phosphatase SHIP-2 causes protein kinase B inactivation and cell cycle arrest in glioblastoma cells.
Taylor V; Wong M; Brandts C; Reilly L; Dean NM; Cowsert LM; Moodie S; Stokoe D
Mol Cell Biol; 2000 Sep; 20(18):6860-71. PubMed ID: 10958682
[TBL] [Abstract][Full Text] [Related]
13. Partially distinct molecular mechanisms mediate inhibitory FcgammaRIIB signaling in resting and activated B cells.
Brauweiler A; Tamir I; Marschner S; Helgason CD; Cambier JC
J Immunol; 2001 Jul; 167(1):204-11. PubMed ID: 11418650
[TBL] [Abstract][Full Text] [Related]
14. A dual role for Src homology 2 domain-containing inositol-5-phosphatase (SHIP) in immunity: aberrant development and enhanced function of b lymphocytes in ship -/- mice.
Helgason CD; Kalberer CP; Damen JE; Chappel SM; Pineault N; Krystal G; Humphries RK
J Exp Med; 2000 Mar; 191(5):781-94. PubMed ID: 10704460
[TBL] [Abstract][Full Text] [Related]
15. Restoration of SHIP activity in a human leukemia cell line downregulates constitutively activated phosphatidylinositol 3-kinase/Akt/GSK-3beta signaling and leads to an increased transit time through the G1 phase of the cell cycle.
Horn S; Endl E; Fehse B; Weck MM; Mayr GW; Jücker M
Leukemia; 2004 Nov; 18(11):1839-49. PubMed ID: 15457186
[TBL] [Abstract][Full Text] [Related]
16. Activation of extracellular signal-regulated kinases ERK1 and ERK2 induces Bcl-xL up-regulation via inhibition of caspase activities in erythropoietin signaling.
Mori M; Uchida M; Watanabe T; Kirito K; Hatake K; Ozawa K; Komatsu N
J Cell Physiol; 2003 May; 195(2):290-7. PubMed ID: 12652655
[TBL] [Abstract][Full Text] [Related]
17. The SH2-containing inositol-5'-phosphatase enhances LFA-1-mediated cell adhesion and defines two signaling pathways for LFA-1 activation.
Rey-Ladino JA; Huber M; Liu L; Damen JE; Krystal G; Takei F
J Immunol; 1999 May; 162(10):5792-9. PubMed ID: 10229812
[TBL] [Abstract][Full Text] [Related]
18. [The mechanism for SHIP gene to induce the apoptosis of human leukemia cell line K562.].
Yang L; Luo JM; Liu XJ; Wen SP; Du XY; Yao L; Yang JC
Sheng Li Xue Bao; 2009 Apr; 61(2):146-54. PubMed ID: 19377826
[TBL] [Abstract][Full Text] [Related]
19. PKB/AKT and ERK regulation of caspase-mediated apoptosis by methylseleninic acid in LNCaP prostate cancer cells.
Hu H; Jiang C; Li G; Lü J
Carcinogenesis; 2005 Aug; 26(8):1374-81. PubMed ID: 15845651
[TBL] [Abstract][Full Text] [Related]
20. Dual role of SRC homology domain 2-containing inositol phosphatase 2 in the regulation of platelet-derived growth factor and insulin-like growth factor I signaling in rat vascular smooth muscle cells.
Sasaoka T; Kikuchi K; Wada T; Sato A; Hori H; Murakami S; Fukui K; Ishihara H; Aota R; Kimura I; Kobayashi M
Endocrinology; 2003 Sep; 144(9):4204-14. PubMed ID: 12933696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
